MARAGANORE JOHN

CIK 00011804329 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001180432

Recent Transactions

50 trades

Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 total
Award
Rapport Therapeutics, Inc.$RAPP
Stock Option (Right to Buy)
2025-06-17+21,850→ 21,850 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2025-06-04+33,662→ 33,662 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-18+16,000→ 16,000 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2024-06-05+23,114→ 23,114 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2023-06-29+48,128→ 48,128 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-06-15+12,000→ 12,000 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-06-06+16,532→ 16,532 total
Gift
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-09-20−1,500→ 28,528 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2022-09-01+10,391→ 10,391 total
Award
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2022-07-11+614,013→ 614,013 total
Award
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2022-07-11+614,013→ 614,013 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-06-21+4,975→ 4,975 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2022-06-21+29,307→ 29,307 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-05-20−1,585→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-05-20+1,585→ 30,028 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-01-18+24,000→ 24,000 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-22$190.50/sh−2→ 227,982 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-22$186.02/sh−319→ 227,663 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-22$189.13/sh−6,315→ 227,984 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-21+14,167→ 234,299 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$119.13/sh+839→ 217,764 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−839→ 51,661 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$42.22/sh+2,368→ 220,132 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$88.95/sh+1,124→ 216,925 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$96.45/sh+1,036→ 215,801 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−1,036→ 73,964 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−1,124→ 63,876 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−2,368→ 22,632 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$7.10/sh+33,978→ 248,743 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$170.36/sh−10,365→ 238,378 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$171.35/sh−7,742→ 230,636 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$172.22/sh−14,518→ 216,118 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$174.34/sh−670→ 214,765 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$173.25/sh−683→ 215,435 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-11-12−33,978→ 0 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2021-11-05+13,133→ 13,133 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-08-13−33,979→ 33,978 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$198.93/sh−4,160→ 242,143 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$201.55/sh−214→ 214,765 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$200.84/sh−3,828→ 214,979 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$7.10/sh+33,979→ 248,744 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$198.02/sh−2,441→ 246,303 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$199.92/sh−23,336→ 218,807 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-05-28+1,686→ 28,443 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-05-28−1,686→ 0 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2021-05-20+8,888→ 8,888 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2021-05-20+1,585→ 1,585 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-05-13$134.37/sh−1,023→ 214,765 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-05-13$132.32/sh−3,481→ 217,412 total

MARAGANORE JOHN

Recent Transactions

Companies

Recent Filings

Address